Share Price.com
Share Search

Shield Thera Share Price


Share Price: 33.50   Bid / Ask: 33.00 / 34.00   High: 34.00   Low: 33.00



Shield Thera is listed on the London Stock Exchange with ticker code STX, and is part of the Pharmaceuticals & Biotechnology sector. It has a market capitalisation of £39.00 m, with 116,426,000 shares in issue. Over the last year, Shield Thera has traded in a range of 144.90p, peaking at a high of 160.00p, with a low of 15.10p.


Shield Thera Share Price Value

Shield Thera Share Price
Shield Thera
Price33.50
Short CodeSTX
Change Today0.00
%ge Change0.00 %
Time16:57:10
High34.00
Low33.00
Open33.50
Yesterdays Close33.50
Volume Traded Today0
Shield Thera Share Price
Intra-day chart for Shield Thera
Shield Thera Intraday Chart
Shield Thera Intraday graph
Shield Thera Intraday Chart


Today’s Trade Volumes for Shield Thera

Recent Trades for STX

Recent Share Trades for Shield Thera (STX) (streaming)

Date
Time
Trade Prc
Volume
Value (approx)
11-Oct-18
10:31:31
34.00
-30,000
-10.20k
11-Oct-18
10:31:31
34.00
30,000
10.20k
15-Oct-18
15:24:27
33.00
10,000
3,300
15-Oct-18
10:34:38
34.00
1,000
340.00
12-Oct-18
16:26:34
31.00
15,151
4,697
11-Oct-18
10:31:31
34.00
30,000
10.20k
10-Oct-18
08:01:38
33.00
5,513
1,819
9-Oct-18
16:01:20
33.00
10,000
3,300
8-Oct-18
13:07:10
34.00
276
93.84


6 Month Graph for Shield Thera

Shield Thera 6 month graph

Share News for Shield Thera

HeadlineDate
Shield Therapeutics gets FDA confirmation of new drug application1 Oct '18
Director Deals - Shield Therapeutics Plc (STX)24 Sep '18
Broker Forecast - Peel Hunt issues a broker note on Shield Therapeutics Plc24 Sep '18
Broker Forecast - Liberum Capital issues a broker note on Shield Therapeutics Plc20 Sep '18
Shield Therapeutics posts loss; inks sales pact with Norgine19 Sep '18
Shield Therapeutics says iron deficiency treatment sales rise in Germany, UK23 Jul '18
Shield Therapeutics chairman Andrew Heat standing down5 Jun '18
Shield Therapeutics losses deepen, to cut headcount and promotional spending11 Apr '18
Shield Therapeutics to re-submit US drug application without more trials6 Apr '18
Shield Therapeutics gets extended European approval for iron-deficiency treatment27 Mar '18



Useful information about Shield Thera



Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News



SharePrice.com will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.